Contribution: Industrial Research Assistance Program – Contributions to Firms
BioAro Inc
$5,000.00
Canadian Life Sciences co-innovation mission to Japan – October 2025
EF 2025-26 · 2025-09-01
Résumé
BioAro is a Canadian AI-Biotech developing AI-guided Precision Medicine through multi-OMICS data analysis, including whole genome (WGS), exome (WES) & microbiome sequencing, cell-free DNA testing, epigenetics & transcriptomics. BioAro’s proprietary AI-driven analytics platform, PanOmiQ, processes this high-dimensional multi-OMICS data for actionable clinical output. These have helped commercialize the BioSport (high performance athletes), BioMYND (mental health) & Biogut (gut wellness & nutrition) programs. BioAro is currently focusing on Drug Development & Discovery, Drug Repurposing & Pharmacogenomics, including in-silico drug design & simulation of clinical trials. BioAro has also built a high performance computing centre
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Calgary|Calgary, Alberta, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
787849462
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2025-12-03
Agreement Number
1037489
Agreement Start Date
2025-09-01
Agreement Title
Canadian Life Sciences co-innovation mission to Japan – October 2025
Agreement Title (French)
Mission de co-innovation des sciences de la vie canadiennes au Japon - octobre 2025
Agreement Type
Contribution
Agreement Value
$5,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
BioAro is a Canadian AI-Biotech developing AI-guided Precision Medicine through multi-OMICS data analysis, including whole genome (WGS), exome (WES) & microbiome sequencing, cell-free DNA testing, epigenetics & transcriptomics. BioAro’s proprietary AI-driven analytics platform, PanOmiQ, processes this high-dimensional multi-OMICS data for actionable clinical output. These have helped commercialize the BioSport (high performance athletes), BioMYND (mental health) & Biogut (gut wellness & nutrition) programs. BioAro is currently focusing on Drug Development & Discovery, Drug Repurposing & Pharmacogenomics, including in-silico drug design & simulation of clinical trials. BioAro has also built a high performance computing centre
Description (French)
BioAro est une entreprise canadienne de biotechnologie spécialisée dans l’IA qui développe une médecine de précision guidée par l’IA grâce à l’analyse de données multi-OMICS, notamment le séquençage du génome entier (WGS), de l’exome (WES) et du microbiome, les tests d’ADN libre, l’épigénétique et la transcriptomique. La plateforme d’analyse exclusive de BioAro, PanOmiQ, traite ces données multi-OMICS de haute dimension pour obtenir des résultats cliniques exploitables. Cela a permis de commercialiser les programmes BioSport (athlètes de haut niveau), BioMYND (santé mentale) et Biogut (mieux-être intestinal et nutrition). BioAro se concentre actuellement sur le développement et la découverte de médicaments, la réorientation des médicaments et la pharmacogénomique, y compris la conception de médicaments in silicio et la simulation d’essais cliniques. BioAro a également construit un centre de calcul haute performance.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Calgary Centre
Federal Riding (French)
Calgary-Centre
Federal Riding Number
48004
NAICS Code
621510
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
787849462
Recipient City
Calgary|Calgary
Recipient Country
CA
Recipient Legal Name
BioAro Inc
Recipient Operating Name
BioAro Inc
Recipient Postal Code
T2P 0L4
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2025-2026-Q3-1037489
